Please login to the form below

Not currently logged in
Email:
Password:

New Accounts, October, 2006 - Advertising

The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period July to September 2006 inclusive
The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period July to September 2006 inclusive. Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets.

To submit an entry for New Accounts, email new_accounts@pmlive.com

AstraZeneca

Symbicort (multimedia)

Respiratory

RFA Advertising & Marketing

British Medical Journal

Clinical Evidence

N/A

The Foundry

Eisai/Janssen-Cilag

Pariet

Gastrointestinal

Dewar Alexander

Kogen

Diclomax

Arthritis and pain

Swordfish Advertising

Janssen-Cilag

Multimedia project

Migraine

RFA Advertising & Marketing

Novartis

Diovan/CoDiovan

Cardiovascular

ICC (Lowe Healthcare WW)

Pfizer Consumer Healthcare UK

Media activity

OTC and POM portfolio

Medical Media Services

ProStrakan

Rapinyl

Pain management

Life

2nd September 2008

Share

Subscribe to our email news alerts

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

Millennials: the wellness generation
Looking at the results from a global healthcare research study focusing on the patients of the future...
The problem with clinical trials (and how virtual insight-gathering can help)
While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
The rise of digital healthcare – fuelled by open innovation in healthtech hubs
How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of drug development...